IMMUNE DONORS CAN PROTECT MARROW-TRANSPLANT RECIPIENTS FROM SEVERE CYTOMEGALOVIRUS INFECTIONS
- 1 April 1987
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 329 (8536) , 774-776
- https://doi.org/10.1016/s0140-6736(87)92800-5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Production of anti‐cytomegalovirus antibody following T‐cell depleted bone marrow transplantBritish Journal of Haematology, 1986
- An improved radioimmunoassay method for the detection of IgG antibodies against cytomegalovirusJournal of Virological Methods, 1986
- Risk Factors for Cytomegalovirus Infection after Human Marrow TransplantationThe Journal of Infectious Diseases, 1986
- TRANSFER OF A FUNCTIONING HUMORAL IMMUNE SYSTEM IN TRANSPLANTATION OF T-LYMPHOCYTE-DEPLETED BONE MARROWThe Lancet, 1986
- Interstitial Pneumonitis After Bone Marrow TransplantationAnnals of Internal Medicine, 1986
- Virological and serological diagnosis of cytomegalovirus infection in bone marrow allograft recipientsJournal of Medical Virology, 1985
- Molecular Epidemiology of Cytomegalovirus Infections Associated with Bone Marrow TransplantationAnnals of Internal Medicine, 1985
- RAPID DIAGNOSIS OF CYTOMEGALOVIRUS INFECTION IN IMMUNOCOMPROMISED PATIENTS BY DETECTION OF EARLY ANTIGEN FLUORESCENT FOCIThe Lancet, 1984
- DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTSThe Lancet, 1984